Eurofins CDMO Europe
CDMO Drug Development Support
- B2B
- Manufacturing
- Professional services
- Sales-led purchase
About Eurofins CDMO Europe
Provides contract development and manufacturing for APIs, drug substance, and drug product, supporting biopharmaceutical companies with various services from preclinical to clinical milestones.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Fontenilles, Occitanie, France
- Founded
- 2010
- Revenue
- $37.2M – $294MTamtam estimate
- Website
- eurofins.com
Eurofins CDMO Europe in the news
- Die Eurofins-Aktie steigt nach Ausbau der CDMO-Kapazitäten und stabiler Kursentwicklung
Eurofins CDMO Alphora expanded its high-potency API development and manufacturing capacities in Canada to strengthen its CDMO offerings in North America, leading to a slight increase in Eurofins stock.
- Eurofins stock holds steady as CDMO unit expands Canadian high-potency capacity
Eurofins Scientific SE's stock performance is strong, with its CDMO unit expanding high-potency API capabilities in Canada.
- Eurofins CDMO Alphora Expands Capacity and HPAPI Capabilities
Eurofins CDMO Alphora expanded its laboratory and high-potency active pharmaceutical ingredient capabilities to support increased demand for drug development and manufacturing.
- Eurofins Scientific (ENXTPA:ERF) Expands Alphora Capacity On A Valuation Story That Still Looks Open
Eurofins Scientific expanded its CDMO Alphora unit's capacity for high potency API development, leading to an 18.83% share price increase over three months, with the company currently assessed as 2.9% undervalued despite concerns about acquisition integration and cash flow from heavy investments.
- Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities
Eurofins CDMO Alphora expanded its kilolab and high-potency development and manufacturing capabilities to support complex drug development.
Eurofins CDMO Europe at a glance
Eurofins CDMO Europe is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Fontenilles, Occitanie, France.
Eurofins CDMO Europe was founded in 2010.
Eurofins CDMO Europe has 251–1,000 employees.
Eurofins CDMO Europe's revenue is $37.2M – $294M (Tamtam estimate).
Selling to companies like Eurofins CDMO Europe?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies